C5AR1 抗体

Hornum, Hansen, Tornehave, Fjording, Colmenero, Wätjen, Søe Nielsen, Bliddal, Bartels: "C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid." in: PLoS ONE, Vol. 12, Issue 12, pp. e0189017, (2018) (PubMed).

Pundir, MacDonald, Kulka: "The Novel Receptor C5aR2 Is Required for C5a-Mediated Human Mast Cell Adhesion, Migration, and Proinflammatory Mediator Production." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 195, Issue 6, pp. 2774-87, (2015) (PubMed).

Reis, Chen, Sfyroera, Monk, Köhl, Ricklin, Lambris: "C5a receptor-dependent cell activation by physiological concentrations of desarginated C5a: insights from a novel label-free cellular assay." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 189, Issue 10, pp. 4797-805, (2012) (PubMed).

Manthey, Thomas, Shiels, Zernecke, Woodruff, Rolfe, Taylor: "Complement C5a inhibition reduces atherosclerosis in ApoE-/- mice." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 25, Issue 7, pp. 2447-55, (2011) (PubMed).

Camous, Roumenina, Bigot, Brachemi, Frémeaux-Bacchi, Lesavre, Halbwachs-Mecarelli: "Complement alternative pathway acts as a positive feedback amplification of neutrophil activation." in: Blood, Vol. 117, Issue 4, pp. 1340-9, (2011) (PubMed).

Shagdarsuren, Bidzhekov, Mause, Simsekyilmaz, Polakowski, Hawlisch, Gessner, Zernecke, Weber: "C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice." in: Circulation, Vol. 122, Issue 10, pp. 1026-36, (2010) (PubMed).

Conway Morris, Kefala, Wilkinson, Dhaliwal, Farrell, Walsh, Mackenzie, Reid, Davidson, Haslett, Rossi, Sallenave, Simpson: "C5a mediates peripheral blood neutrophil dysfunction in critically ill patients." in: American journal of respiratory and critical care medicine, Vol. 180, Issue 1, pp. 19-28, (2009) (PubMed).

Baelder, Fuchs, Bautsch, Zwirner, Köhl, Hoymann, Glaab, Erpenbeck, Krug, Braun: "Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 174, Issue 2, pp. 783-9, (2005) (PubMed).